Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Receivables (2020 - 2026)

Sotera Health has reported Receivables over the past 6 years, most recently at $163.7 million for Q4 2025.

  • For Q4 2025, Receivables rose 5.27% year-over-year to $163.7 million; the TTM value through Dec 2025 reached $163.7 million, up 5.27%, while the annual FY2025 figure was $163.7 million, 5.27% up from the prior year.
  • Receivables for Q4 2025 was $163.7 million at Sotera Health, down from $179.7 million in the prior quarter.
  • Over five years, Receivables peaked at $179.7 million in Q3 2025 and troughed at $110.5 million in Q1 2021.
  • A 5-year average of $139.0 million and a median of $133.7 million in 2022 define the central range for Receivables.
  • On a YoY basis, Receivables climbed as much as 35.41% in 2023 and fell as far as 11.76% in 2023.
  • Year by year, Receivables stood at $111.3 million in 2021, then rose by 9.77% to $122.2 million in 2022, then surged by 35.41% to $165.5 million in 2023, then fell by 6.01% to $155.5 million in 2024, then rose by 5.27% to $163.7 million in 2025.
  • Business Quant data shows Receivables for SHC at $163.7 million in Q4 2025, $179.7 million in Q3 2025, and $165.1 million in Q2 2025.